Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-11-19

FDA Approved: DARUNAVIR — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves Lupin Pharmaceuticals' supplemental application for Darunavir, enabling the sale of a generic darunavir product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Darunavir (darunavir)

Snippet

SUPPL AP for DARUNAVIR (DARUNAVIR)